Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible Escherichia coli in Japan
- 1 February 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (2)
Abstract
We investigated the epidemiology and resistance mechanisms of ampicillin-sulbactam-nonsusceptible Escherichia coli, focusing on the role of TEM-1 β-lactamase. We collected all non-duplicate E. coli clinical isolates at 10 Japanese hospitals during December 2014 and examined their antimicrobial susceptibility, β-lactamases, TEM-1 transferability, TEM-1 β-lactamase activity, outer membrane protein profile, membrane permeability, and clonal genotypes. Among the 329 isolates, 95 were ampicillin-sulbactam nonsusceptible. Of these ampicillin-sulbactam-nonsusceptible isolates, β-lactamases conferring resistance to sulbactam such as AmpC were present in 33%. Hyperproduction of sulbactam-susceptible β-lactamases, TEMs with a strong promoter, were rare (5%). The remaining 59 isolates (62%) had only sulbactam-susceptible β-lactamases, including TEM-1 with a wild-type promoter (n = 28), CTX-Ms (n = 13), or both (n = 17). All 45 transconjugants from 96 donors with TEM-1 had higher ampicillin-sulbactam MICs (4-96 mg/l) than the recipient (2 mg/L). In donors with only TEM-1, TEM-1 activity correlated with the 50% inhibitory concentration of sulbactam and ampicillin-sulbactam MICs. The decreased membrane permeability of sulbactam was associated with an increased ampicillin-sulbactam MIC. The reduced permeability was partly attributable to deficient outer membrane proteins, which were observed in 57% of the ampicillin-sulbactam-nonsusceptible isolates with only TEM-1 and a wild-type promoter. Sequence type 131 was the most common clonal type (52%). TEM-1 with a wild-type promoter primarily contribute to ampicillin-sulbactam nonsusceptibility in E. coli with partial support of other mechanisms such as the reduced permeability. Conjugative TEM-1 and clonal spread of ST131 may contribute to the prevalence of Japanese ampicillin-sulbactam-nonsusceptible isolates.Keywords
This publication has 40 references indexed in Scilit:
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- High-Resolution Two-Locus Clonal Typing of Extraintestinal Pathogenic Escherichia coliApplied and Environmental Microbiology, 2012
- Practical Approach for Reliable Detection of AmpC Beta-Lactamase-Producing EnterobacteriaceaeJournal of Clinical Microbiology, 2011
- Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended- Spectrum-β-Lactamase-Producing Escherichia coli and the Role of TEM-1 HyperproductionAntimicrobial Agents and Chemotherapy, 2011
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2010
- Three Decades of β-Lactamase InhibitorsClinical Microbiology Reviews, 2010
- Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004Antimicrobial Agents and Chemotherapy, 2009
- Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamasesJournal of Antimicrobial Chemotherapy, 2008
- Plasmid Replicon Typing of Commensal and Pathogenic Escherichia coli IsolatesApplied and Environmental Microbiology, 2007